Shiro Suzuki

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Prognostic Factors

Laparoscopic Surgery

Endometrial Cancer

Top Venues

Journal of gynecologic oncology

Journal of surgical case reports

Cancer medicine

The journal of obstetrics and gynaecology research

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Yusuke Shimizu, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama
Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer. Cancer medicine 13 (7) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Ryosuke Uekusa, Akira Yokoi, Eri Watanabe, Kosuke Yoshida, Masato Yoshihara, Satoshi Tamauchi, Yusuke Shimizu, Yoshiki Ikeda, Nobuhisa Yoshikawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama
Real-world data of poly (ADP-ribose) polymerase inhibitor response in Japanese patients with ovarian cancer. Cancer medicine 13 (7) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology 35 (2) (2024)
Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijma, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae-Weon Kim, Byoung Gie Kim, Peng-Hui Wang, Ting-Chang Chang, Keiko Yamamoto, Shirong Han, Jodi-Ann Mckenzie, Robert J Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim
Analysis of East Asia Subgroup in Study 309/KEYNOTE-775: Lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer. Journal of gynecologic oncology (2024)
Saki Kotaka, Asumi Okumura, Yosuke Kawai, Kota Okamoto, Yasuyuki Kishigami, Takaharu Yamawaki, Kenji Nagao, Hirata Toru, Shiro Suzuki
Paclitaxel-carboplatin plus bevacizumab therapy for advanced neuroendocrine carcinoma of the uterine cervix: A retrospective case series. The journal of obstetrics and gynaecology research (2023)
Saki Kotaka, Asumi Okumura, Yosuke Kawai, Kota Okamoto, Yasuyuki Kishigami, Takaharu Yamawaki, Kenji Nagao, Toru Hirata, Shiro Suzuki
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer. Journal of gynecologic oncology (2023)
Kentaro Kaji, Hirofumi Tsubouchi, Masahiko Mori, Shiro Suzuki
Postoperative transverse colon necrosis due to mesenteric injury during laparoscopic surgery for endometrial carcinoma. Journal of surgical case reports 2023 (1) (2023)
Kentaro Kaji, Hirofumi Tsubouchi, Masahiko Mori, Shiro Suzuki
Postoperative transverse colon necrosis due to mesenteric injury during laparoscopic surgery for endometrial carcinoma. Journal of surgical case reports 2023 (1) (2023)
Mayu Ukai, Shiro Suzuki, Masato Yoshihara, Akira Yokoi, Nobuhisa Yoshikawa, Hiroaki Kajiyama, Fumitaka Kikkawa
Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary? International journal of clinical oncology (2021)
Toshiaki Yoshikawa, Zhiwen Wu, Satoshi Inoue, Hitomi Kasuya, Hirokazu Matsushita, Yusuke Takahashi, Hiroaki Kuroda, Waki Hosoda, Shiro Suzuki, Yuki Kagoya
Genetic ablation of PRDM1 in antitumor T cells enhances therapeutic efficacy of adoptive immunotherapy. Blood (2021)
Hiroaki Kajiyama, Shiro Suzuki, Nobuhisa Yoshikawa, Satoshi Tamauchi, Kiyosumi Shibata, Fumitaka Kikkawa
The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma. Journal of gynecologic oncology 31 (4) (2020)
Masato Yoshihara, Hiroaki Kajiyama, Satoshi Tamauchi, Shiro Suzuki, Kunihiko Takahashi, Shigeyuki Matsui, Fumitaka Kikkawa
Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis. Journal of gynecologic oncology 30 (6) (2020)
Kosuke Yoshida, Nobuhisa Yoshikawa, Akira Shirakawa, Kaoru Niimi, Shiro Suzuki, Hiroaki Kajiyama, Fumitaka Kikkawa
Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma. Journal of gynecologic oncology 30 (6) (2020)